Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Morula-derived human embryonic stem cells.

Nick Strelchenko1, Oleg Verlinsky, Valeri Kukharenko

  • 1Reproductive Genetics Institute, Chicago, IL, USA. rgi@flash.net

Reproductive Biomedicine Online
|January 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whole genome sequencing of <i>CCR5</i> CRISPR-Cas9-edited Mauritian cynomolgus macaque blastomeres reveals large-scale deletions and off-target edits.

Frontiers in genome editing·2023
Same author

Genome editing of CCR5 by CRISPR-Cas9 in Mauritian cynomolgus macaque embryos.

Scientific reports·2020
Same author

Successful early fetal sex determination using cell-free fetal DNA isolated from maternal capillary blood: A pilot study.

European journal of obstetrics & gynecology and reproductive biology: X·2019
Same author

PGD for cystic fibrosis patients and couples at risk of an additional genetic disorder combined with 24-chromosome aneuploidy testing.

Reproductive biomedicine online·2013
Same author

PGD for inherited cardiac diseases.

Reproductive biomedicine online·2012
Same author

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.

Nature biotechnology·2011
Same journal

HealthTech for reproduction: promises, perils and the evidence gap.

Reproductive biomedicine online·2026
Same journal

Building the RBMO Scientific Community.

Reproductive biomedicine online·2026
Same journal

Time to reconsider who the freeze-all approach benefits: a matched cohort analysis of over 9000 embryo transfers.

Reproductive biomedicine online·2026
Same journal

Structured counselling and its association with IVF cycle cancellations and patient adherence.

Reproductive biomedicine online·2026
Same journal

hsa-miR-375-3p in embryo culture medium exosomes as a preimplantation non-invasive biomarker for predicting live birth after IVF.

Reproductive biomedicine online·2026
Same journal

Promoting family-building strategies among key stakeholders: the International Federation of Fertility Societies More Joy™ campaign.

Reproductive biomedicine online·2026
See all related articles

Researchers successfully derived human embryonic stem (ES) cells from morula embryos, demonstrating their potential for regenerative medicine. These morula-derived ES cells exhibit characteristics identical to blastocyst-derived ES cells.

Area of Science:

  • Stem Cell Biology
  • Developmental Biology
  • Reproductive Medicine

Background:

  • Human embryonic stem (ES) cells are typically derived from blastocysts.
  • The potential of using earlier developmental stages, like the morula, for ES cell derivation remains unexplored.
  • Morula stage embryos are accessible through assisted reproduction and preimplantation genetic diagnosis.

Purpose of the Study:

  • To investigate the feasibility of deriving human ES cell lines from morula stage embryos.
  • To characterize the properties of morula-derived ES cells and compare them to blastocyst-derived ES cells.

Main Methods:

  • Development of an original technique for deriving ES cells from human morula.
  • Characterization of derived cell lines using morphological analysis and specific stem cell marker expression (Oct-4, TRA-2-39, SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, alkaline phosphatase).

Related Experiment Videos

  • Assessment of in vitro differentiation potential of morula-derived ES cells.

    • Main Results:

    • Successfully established eight human morula-derived ES cell lines.
    • Morula-derived ES cells showed no morphological differences compared to blastocyst-derived ES cells.
    • Identical expression of key ES cell markers and alkaline phosphatase was observed in both morula- and blastocyst-derived ES cells, even in feeder-free culture.
    • Morula-derived ES cells demonstrated spontaneous in vitro differentiation into various cell types, including neuron-like and primitive cardiocyte-like cells.

    Conclusions:

    • Human morula is a viable source for deriving pluripotent ES cell lines.
    • Morula-derived ES cells possess characteristics and differentiation potential comparable to blastocyst-derived ES cells.
    • This finding expands the potential sources for human ES cells, with implications for regenerative medicine and assisted reproduction programs.